BioVie Says Recently Completed Funding Round Provides Opportunity To Further Its Clinical Priorities In Parkinson's Disease, Alzheimer's Disease, And Ascites/Liver Disease, The Company Continues To Explore Longevity And Aging In Conjunction With Partners
BioVie Says Recently Completed Funding Round Provides Opportunity To Further Its Clinical Priorities In Parkinson's Disease, Alzheimer's Disease, And Ascites/Liver Disease, The Company Continues To Explore Longevity And Aging In Conjunction With Partners
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.